John Liu is an Ophthalmology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7117 Brockton Ave
Riverside, CA 925062658
Telephone
951-321-6356Provider last certified this registry record 7 Apr 2025.
Clinical trials
- 24-hour IOP-lowering Effect of 0.01% Bimatoprost
Sponsor: University of California, San Diego
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year20255 payments
- Regeneron Healthcare Solutions, Inc.Program year20251 payment
- NEW WORLD MEDICAL,INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
64.3%Corticosteroid18.7%Prednisolone Acetate100%Part D≥239 patientsProstaglandin Analog16.1%Latanoprost95%Travoprost5%Part D<11 patients+ 6 more classes in this area
Cancer & immunology
13.4%Calcineurin inhibitor13.4%Cyclosporine66%Restasis34%Part D≥78 patientsMusculoskeletal
13.4%Nonsteroidal Anti-inflammatory Drug12.3%Diclofenac Sodium100%Part D≥198 patientsCyclooxygenase Inhibitor1.1%Ketorolac Tromethamine100%Part D≥20 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 1991–2026 per NIH RePORTER. The latest:
- Defining the cell intrinsic and tumor immune microenvironment mechanisms of DNA-PKcs in radiotherapy resistance in glioblastoma
University of California, San Francisco
FY2026$286,881K08CA304353 - Regulation of neurogenesis by the novel long non-coding RNA Pnky
University of California, San Francisco
FY2016$35,461F30NS092319 - Regulation of neurogenesis by the novel long non-coding RNA Pnky
University of California, San Francisco
FY2015$35,005F30NS092319
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”